Identification of potential diagnostic markers among Burkholderia cenocepacia and B. multivorans supernatants.
Patients with cystic fibrosis (CF) are susceptible to chronic respiratory infections with a number of bacterial pathogens. Among them, the Burkholderia cepacia complex (Bcc) bacteria, consisting of nine related species, have emerged as problematic CF pathogens due to their antibiotic resistance, incidence of nosocomial infection, and person-to-person transmission. Bcc organisms present the clinical microbiologist with a diagnostic dilemma due to the lack of phenotypic biochemical or growth-related characterization tests that reliably distinguish among these organisms. The complex taxonomy of the Bcc species colonizing the CF respiratory tract makes accurate identification problematic. Despite the clinical implications of Bcc identification, a clinical laboratory differentiation of species within the Bcc is lacking. Additionally, no commercial assays are available to further identify the Bcc species. In the current study, secretory proteins present in the cultured supernatants of Burkholderia cenocepacia and Burkholderia multivorans were analyzed by two-dimensional gel electrophoresis (2-DE), followed by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). To assess differential expression, protein spots of B. cenocepacia and B. multivorans that were unique or displayed different intensities were chosen for MALDI-TOF MS analysis. In total, 341 protein spots were detected, of which 23 were unique to each species, demonstrating that potential diagnostic candidates between these two members of the Bcc exist.
Mott
Tiffany
T
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas 77555-1140, USA.
Soler
Michael
M
Grigsby
Sierrah
S
Medley
Ronald
R
Whitlock
Gregory C
GC
D001426:Bacterial Proteins / Q000032:analysis* / Q000378:metabolism; D015373:Bacterial Typing Techniques / Q000379:methods; D042602:Burkholderia cepacia complex / Q000737:chemistry* / Q000145:classification* / Q000378:metabolism; D003470:Culture Media / Q000737:chemistry; D015180:Electrophoresis, Gel, Two-Dimensional; D006801:Humans; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
D001426:Bacterial Proteins; D003470:Culture Media
J Clin Microbiol. 1999 Jul;37(7):2158-64
10364579
Proteomics. 2007 May;7(10):1702-18
17443846
J Immunol Methods. 1988 Nov 25;115(1):61-9
3192948
Clin Microbiol Rev. 1991 Jan;4(1):35-51
1900735
APMIS. 2007 Apr;115(4):311-8
17504297
Microbiol Mol Biol Rev. 2006 Sep;70(3):755-88
16959968
J Clin Epidemiol. 1990;43(2):125-31
2303842
J Med Microbiol. 2002 Nov;51(11):937-940
12448677
Infect Immun. 1991 Jun;59(6):1905-10
1903768
FEMS Microbiol Lett. 2005 Oct 15;251(2):273-80
16140471
Chest. 2000 Jun;117(6):1661-5
10858399
Nat Med. 1995 Jul;1(7):661-6
7585148
Expert Rev Proteomics. 2007 Apr;4(2):239-48
17425459
J Clin Microbiol. 2000 Sep;38(9):3165-73
10970351
J Clin Microbiol. 1996 Apr;34(4):886-91
8815102
Int J Syst Evol Microbiol. 2001 Jul;51(Pt 4):1481-1490
11491349
J Pediatr. 1985 Sep;107(3):382-7
4032134
Proteomics. 2005 Apr;5(6):1544-57
15838904
J Clin Microbiol. 2007 Sep;45(9):3105-8
17626169
Proteomics. 2006 Jan;6(1):207-16
16294309
Vaccine. 2010 Feb 3;28(5):1318-24
19944788
Annu Rev Phytopathol. 2001;39:225-58
11701865
Nat Rev Microbiol. 2005 Feb;3(2):144-56
15643431
Infect Immun. 2002 May;70(5):2715-20
11953418
J Clin Microbiol. 2000 Aug;38(8):3112-5
10921992
J Bacteriol. 1992 Jun;174(11):3423-8
1592799